Elegen sets a new benchmark for clonal, cell-free synthetic DNA with ENFINIA, delivering unmatched length and accuracy from ...

The global Cell-free fetal DNA testing market is estimated to be valued at USD 1,687.8 million in 2025 and is projected to reach USD 3,051.5 million by 2035, registering a compound annual growth rate ...

Elegen today announced significant price reductions across its ENFINIAtm DNA portfolio, now offering high-accuracy, clonal, cell-free synthetic DNA with list pricing as low as $0.07 per base pair.

Dublin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The "Cell-Free DNA (cfDNA) Blood Collection Tube Market Report 2025" has been added to ResearchAndMarkets.com's offering. The cell-free DNA (cfDNA) blood ...

The COVID-19 pandemic thrust messenger RNA (mRNA) into the spotlight, underscoring its promise as a nimble, programmable platform for delivering genetic instructions directly to cells. The success of ...

Professor Norikazu Ichihashi and his colleagues at the University of Tokyo have successfully induced gene expression from a DNA, characteristic of all life, and evolution through continuous ...

When cells in the body die, they release DNA. This DNA, known as cell-free DNA (cfDNA), makes its way into the bloodstream where it gets chopped up by enzymes, and in minutes to hours, the liver pulls ...

Elegen has launched ENFINIA™ IVT Ready DNA, a cell-free gene synthesis platform that provides full-length linear DNA templates encoded poly(A) tails for in vitro transcription. The templates are ...

Modeling Population-Level Impacts of Cell-Free DNA Screening for Colorectal Cancer in Canada - (https://jamanetwork.com/journals/jamaoncology/article-abstract/2833397) ...